The Indian healthcare system is witnessing tremendous growth in the past decade. With rising incomes and awareness, people are opting for advanced medical procedures that require minimally invasive surgeries. However, surgeries often lead to blood loss that needs to be controlled immediately. This is where hemostats play a crucial role in helping surgeons reduce blood loss and facilitate quick recovery for patients.
Hemostats are medical devices or medicines that help control bleeding during surgery by accelerating the blood clotting process. They work at the bleeding site to form a protective layer over it and seal the wound. With rising surgery numbers, the demand for effective hemostats is increasing in India. The government and private healthcare providers are recognizing the need to make quality hemostats widely available across the country.
Types of India Hemostat Used in Hospitals
There are different types of hemostats available in the Indian market based on their mechanism of action:
Mechanical hemostats: These India Hemostat function by applying physical pressure to the bleeding site to plug it. Common examples include gauze, laparotomy pads and muscle strips. They are inexpensive but require additional measures to achieve proper hemostasis.
Topical hemostats: These hemostats work on the wound surface to accelerate clot formation. Examples include platelet gel, thrombin-based products and collagen. They form protective layers to seal wounds but their effects are temporary.
Active hemostats: Containing active ingredients, these hemostats biochemically stimulate the body's clotting process. Popular variants used include oxidized cellulose, gelatin matrix thrombin combinations and synthetic polymer-based hemostats. They provide rapid and reliable hemostasis.
Hemostatic drugs: Medications like tranexamic acid and aminocaproic acid help reduce blood loss by inhibiting fibrinolysis or breakdown of blood clots. They are commonly used along with other hemostatic agents.
Adoption of Advanced India Hemostat Grows
With increasing complexity of surgeries in India, the preference for more effective hemostats is rising. Hospitals are adopting hemostatic products & drugs that deliver faster, reliable and long-lasting hemostasis. Synthetic polymer-based hemostats are gaining popularity due to their ability to stop bleeding quickly, even from capillary vessels.
Their compact, easy to use formulation also reduces application time for surgeons. Leading manufacturers are launching advanced hemostats made from biomaterials that are safe, non-toxic and proven to control both arterial and venous bleedings. Indian doctors recommend products backed by scientific evidence and regulatory approvals from stringent organizations.
Access to Quality Hemostats a Challenge in Rural India
While hemostats are standard equipments in major private and public hospitals today, their availability remains patchy in rural areas. Limited healthcare infrastructure and low budgets restrict the range of hemostatic products that can be stocked or used in district hospitals and primary health centers. Affordability is also a concern for underprivileged patients seeking treatment in such set-ups.
Most patients in villages still rely on conventional mechanical methods for hemostasis due to lack of access to effective modern hemostats. This often results in delayed blood clotting, higher risk of re-bleeding and longer recovery times. To address this, the government is taking initiatives to widen the outreach of subsidized hemostatic products and create awareness among rural clinicians on their advantages. Not-for-profit organizations also support this cause.
Future Outlook for Hemostats Market in India
It is projected that the Indian hemostats market will witness double digit growth rates over the next 5 years, driven by the expansion of healthcare sector. As the country is home to nearly 18% of world's population, the growing prevalence of lifestyle diseases and traumas will positively influence surgical volumes. This will fuel demand for complementary hemostatic products and drugs that facilitate quicker healing.
Manufacturers are launching new amalgamations of hemostatic agents tailored for Indian patients, backed by local clinical evidence. Also, technologies like topical hemostats embedded with medications will gain relevance. Policies enabling wider insurance coverage for advanced surgeries will boost uptake of such associated medical consumables as well. With improving diagnostic capabilities and nation-building initiatives, quality hemostats are bound to reach more remotest parts of India in future.
Hemostats play a pivotal role in supporting India's rising surgical workload and healing millions by reducing blood loss complications. While adoption has increased multi-fold, equitable access still requires addressing, especially in rural areas. Ongoing research promises newer formats that suit Indian conditions even better. Joint efforts by all stakeholders can thereby maximize the clinical and socio-economic impact of these life-saving medical devices.
Get More Insights on- India Hemostat
For Deeper Insights, Find the Report in the Language that You want:
